At a glance
- Early chronic kidney disease often has no symptoms and is found through blood and urine tests.
- Risk is assessed with both estimated filtration and urine albumin, together with cause and change over time.
- Blood-pressure control, selected kidney-protective medicines, medication safety, and individualized nutrition can slow progression.
01
What it is
Chronic kidney disease means an abnormality of kidney structure or function persists long enough to affect health. Kidneys filter waste and fluid, regulate electrolytes and acid balance, help control blood pressure, and support red blood cell and bone health. CKD ranges from mild damage with preserved filtration to kidney failure. A single abnormal creatinine or urine result during illness does not by itself establish chronic disease; persistence and clinical context matter.
02
Symptoms and how it may present
Kidneys remove wastes and excess fluid, balance minerals and acid, help regulate blood pressure, support red-blood-cell production, and contribute to bone health. CKD often develops from diabetes, hypertension, immune disease, inherited conditions, obstruction, or prior kidney injury. Symptoms such as swelling, itching, fatigue, appetite loss, nausea, or breathlessness usually appear later and are not reliable screening tools.
03
Causes and risk factors
Diabetes and hypertension are common causes, but immune, genetic, structural, infectious, obstructive, vascular, and medicine-related disorders also matter. Cause should not be assumed solely because diabetes is present. Risk increases with cardiovascular disease, family history, prior acute kidney injury, older age, and some exposures. CKD is classified by cause, filtration category, and albuminuria category because two people with the same eGFR can have different progression and cardiovascular risk.
04
How chronic kidney disease is diagnosed
Tests should answer a clinical question and be interpreted together with symptoms, examination, and history.
Assessment commonly pairs a blood creatinine-based estimated glomerular filtration rate with a urine albumin-to-creatinine ratio and repeats abnormalities for at least three months. Results are interpreted with age, muscle mass, medicines, hydration, imaging, and clinical context. Monitoring may include blood pressure, potassium, bicarbonate, anemia, bone-mineral measures, cardiovascular risk, and medicine doses that depend on kidney function.
Early kidney disease can be silent. Blood and urine tests answer different questions: creatinine-based eGFR estimates filtration, while urine albumin-to-creatinine ratio (UACR) looks for albumin leakage. Ask for both results and their units; symptoms alone cannot rule out CKD.
One abnormal result does not establish chronic disease. KDIGO recommends repeat testing and evidence that the abnormality has persisted for at least three months, using earlier records and other clinical findings where available. A new abnormal result may instead need prompt assessment for an acute problem; do not simply wait three months without advice.
| Test | Question to ask |
|---|---|
| eGFR (blood) | How does this compare with my earlier filtration results? |
| UACR (urine) | Is albumin elevated, and does the urine test need confirmation? |
05
Treatment options
The best option depends on severity, other conditions, likely benefit and harm, access, and personal priorities.
Treatment addresses the cause and slows progression. Blood-pressure control, ACE inhibitors or ARBs for many people with albuminuria, SGLT2 inhibitors for eligible patients, diabetes care, statins, and avoidance of kidney toxins are important. Later-stage care may treat anemia, acidosis, fluid overload, or mineral-bone disease. Planning for transplant or dialysis begins before an emergency, but many people never reach kidney failure.
06
Daily life and supportive care
A kidney-informed eating plan is individualized; sodium is often limited, while protein, potassium, phosphorus, and fluid advice varies by stage, laboratory results, treatment, and nutrition status. Routine restriction can cause harm if unnecessary. NSAID pain medicines, some contrast procedures, herbal products, creatine, high-dose vitamins, and potassium-containing supplements or salt substitutes deserve review with the care team.
07
Monitoring and follow-up
Follow trends that can change a decision rather than collecting measurements without a purpose.
Follow eGFR and urine albumin trends, blood pressure, potassium and other electrolytes, acid-base status, blood count, bone-mineral measures when indicated, diabetes control, symptoms, and medication dosing. Temporary changes can occur with dehydration, infection, obstruction, or medicine changes, so trends need context. Review every prescription, over-the-counter medicine, supplement, and imaging contrast plan for kidney dosing or injury risk. Monitoring frequency should rise with greater risk or rapid change rather than follow one schedule for everyone.
08
Complications and long-term outlook
Progression is not inevitable and can be slow, stable, or rapid depending on cause, albuminuria, eGFR trend, blood pressure, diabetes, smoking, acute injuries, and treatment. CKD increases cardiovascular risk and can lead to anemia, fluid overload, electrolyte and acid disturbances, bone-mineral disease, itching, poor nutrition, and reduced function. Advanced-care planning should discuss kidney replacement options and conservative care early enough for informed choice, without assuming dialysis is the only goal.
09
When to seek urgent help
CKD increases risks of heart disease, stroke, acute kidney injury, anemia, dangerous potassium changes, bone disease, and kidney failure. Seek urgent help for severe breathlessness, chest pain, confusion, very little urine, rapidly increasing swelling, persistent vomiting, or profound weakness. During dehydration or serious illness, ask promptly about a sick-day medicine plan rather than stopping prescribed treatment without guidance.
10
Questions to discuss with a care team
A guideline describes what tends to help groups of people, but it cannot decide what matters most in one person’s life. Revisit the plan when symptoms, function, other illnesses, pregnancy plans, medicine access, side effects, or personal priorities change. Ask for plain-language reasoning and say directly when cost, time, transport, caregiving, or treatment complexity makes a recommendation unrealistic.
- What evidence supports this diagnosis, and is there another condition we still need to rule out?
- What is the treatment goal, and how do the main options differ in benefit, harm, burden, and cost?
- What should be monitored, how often, and what result would change the plan?
- Which symptoms require a routine appointment, urgent assessment, or emergency care?
Sources
- Chronic Kidney DiseaseNational Institute of Diabetes and Digestive and Kidney Diseases · 2026
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKDKDIGO · 2024Source accessed:
- Chronic Kidney Disease Tests & DiagnosisNIDDK · 2016Source accessed:
- Managing Chronic Kidney DiseaseNational Institute of Diabetes and Digestive and Kidney Diseases · 2026
Revision history
- Source-backed additions and clearer search descriptions prepared with automated assistance. No new clinical review is claimed; earlier editorial dates are retained as legacy metadata.